Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomarker
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
    Technologies and Software
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
JULY 2023LIFE SCIENCES REVIEW4CONTENTSCONTENTSBiotechnology should have Preferred Regulatory Pathways to Catalyze the Bioscience RevolutionLone Dybdal Nilsson, VP of Applied Research in agriculture and Industrial Bioprocessing, NovozymesIN MY OPINIONLAST WORD3412CO V ER S T O R Y08Generative AI (Artificial Intelligence) in BiotechOliver Hesse, VP & Head of Biotech Data Science & Digitalization, Bayer PharmaceuticalsSTEVEN COHEN, EXECUTIVE DIRECTOR, TRANSLATIONAL MEDICINE-ONCOLOGY & INTERNAL MEDICINE, & BUSINESS DEVELOPMENT-IM,DAIICHI SANKYO, INC.THE VITAL INTERSECTION OF ACADEMIA, BIOTECH, AND PHARMA IN PRODUCING MEDICAL THERAPIES
< Page 3 | Page 5 >